Deutsch English Français

Contact

EP3645004

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3645004

EP3645004 - MAGNETIC NANOPARTICLES FOR TARGETED DELIVERY [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 29.03.2024 Database last updated on 18.11.2024
Former	Examination is in progress Status updated on 08.07.2022
Former	Request for examination was made Status updated on 03.04.2020
Former	The international publication has been made Status updated on 04.01.2019
Most recent event Tooltip	29.03.2024	Application deemed to be withdrawn	published on 01.05.2024 [2024/18]
Applicant(s)	For all designated states Otomagnetics, Inc. 12156-B Parklawn Dr Rockville, MD 20852 / US
	[2020/19]
Inventor(s)	01 / SHAPIRO, Benjamin 12156-B Parklawn Dr Rockville MD 20852 / US
	02 / SHUKOOR, Mohammed 12156-B Parklawn Dr Rockville MD 20852 / US
	[2020/19]
Representative(s)	Gregson, Anna Louise Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
	[N/P]
Former [2020/19]	Bond, Christopher William Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München / DE
Application number, filing date	18824766.2	30.06.2018
	[2020/19]
	WO2018US40523
Priority number, date	US201762527274P	30.06.2017 Original published format: US 201762527274 P
	[2020/19]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2019006440
	Date:	03.01.2019
	Language:	EN
	[2019/01]
	Type:	A1 Application with search report
	No.:	EP3645004
	Date:	06.05.2020
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.01.2019 takes the place of the publication of the European patent application.
	[2020/19]
Search report(s)	International search report - published on:	US	03.01.2019
	(Supplementary) European search report - dispatched on:	EP	08.04.2021
Classification	IPC:	A61K9/19, A61K9/50, A61K41/00, A61K9/51, A61K31/496, A61K31/573, A61K31/5383, A61K31/58, A61K45/06, A61K47/69, A61K9/00	[2021/18]
	CPC:	A61K45/06 (EP); A61K9/5094 (EP,US); A61K31/496 (EP,US); A61K31/5383 (EP); A61K31/573 (EP,US); A61K31/58 (EP,US); (+) A61K41/00 (EP); A61K47/6923 (EP); A61K47/6937 (EP); A61K9/0009 (EP); A61K9/19 (EP,US); A61K9/5107 (US); A61K9/5115 (EP); A61K9/5146 (EP,US); A61K9/5153 (EP,US) (-)
	C-Set:	A61K31/496, A61K2300/00 (EP); A61K31/5383, A61K2300/00 (EP); A61K31/573, A61K2300/00 (EP); A61K31/585, A61K2300/00 (EP)
	Former IPC [2020/19]	A61K31/513, A61K31/519, A61K33/24
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/19]
Title	German:	MAGNETISCHE NANOPARTIKEL ZUR GEZIELTEN ABGABE	[2020/19]
	English:	MAGNETIC NANOPARTICLES FOR TARGETED DELIVERY	[2020/19]
	French:	NANOPARTICULES MAGNÉTIQUES POUR L'ADMINISTRATION CIBLÉE	[2020/19]
Entry into regional phase	17.01.2020	National basic fee paid
	17.01.2020	Search fee paid
	17.01.2020	Designation fee(s) paid
	17.01.2020	Examination fee paid
Examination procedure	17.01.2020	Examination requested [2020/19]
	08.11.2021	Amendment by applicant (claims and/or description)
	08.07.2022	Despatch of a communication from the examining division (Time limit: M06)
	12.01.2023	Reply to a communication from the examining division
	25.05.2023	Despatch of a communication from the examining division (Time limit: M06)
	05.12.2023	Application deemed to be withdrawn, date of legal effect [2024/18]
	03.01.2024	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/18]
Fees paid	Renewal fee
	06.10.2020	Renewal fee patent year 03
	17.08.2021	Renewal fee patent year 04
	30.06.2022	Renewal fee patent year 05
	28.12.2023	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	30.06.2020	03 M06 Fee paid on 06.10.2020
	30.06.2021	04 M06 Fee paid on 17.08.2021
	30.06.2023	06 M06 Fee paid on 28.12.2023
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO2004093643 (PHILADELPHIA CHILDREN HOSPITAL [US], et al) [A] 1-15 * page 37, line 29 ** page 54, line 25 - page 56, line 13; examples 1,2 *;
		[XAY]US2007264199 (LABHASETWAR VINOD D [US], et al) [X] 1-5,7-10,15 * paragraphs [0011] - [0014] - [0 26] , [0 62] - [0065]; example 6; claim 1 * * paragraph [0017] - paragraph [0018]; table 2 * * paragraph [0071]; example 12 * [A] 11-13 [Y] 6,14;
		[XAYI]US2009082611 (LEVY ROBERT J [US], et al) [X] 1-3,7-10,14 * paragraph [0003]; claims 1,5 * * paragraphs [0044] , [0 60] * * paragraphs [0045] , [0 53] * * paragraph [0139] - paragraph [0149]; examples 11,12 * [A] 11-13,15 [Y] 6,14 [I] 4,5;
		[XYI]WO2013158549 (UNIV NEBRASKA [US], et al) [X] 1-4,7-10,15 * figure 1; claims 1,22 * * page 6, line 2 - line 4; claim 18 * * page 25, line 27 * * page 26, line 31 - page 28, line 12; example 1 * * page 36, line 23 - page 40, line 9; example 2 * * page 40, line 11 - page 41, line l; example 3 * [Y] 6,14 [I] 5,6,11-13
	International search	[Y]US2003039689 (CHEN JIANBING [US], et al) [Y] 7-9 * ; entire document, especially [0002], [0096] *;
		[Y]WO2004093643 (PHILADELPHIA CHILDREN HOSPITAL [US], et al) [Y] 5 * ; entire document, especially abstract, pg 36 lines 6-15 *;
		[XY]WO2004096190 (UNIV YONSEI SEOUL [KR], et al) [X] 1-4, 6 * ; entire document, especially pg 1 lines 4-8, pg 2 line 22 - pg 3 line 1, pg 3 lines 6-9, pg 6 line - pg 7 line 3, pg 7 lines 4-7 * [Y] 5, 7-9, 15;
		[Y]US2010255102 (BOSCH H WILLIAM [US], et al) [Y] 18 * ; entire document, especially abstract *;
		[Y]US2011275704 (TROIANO GREG [US], et al) [Y] 15 * ; entire document, especially abstract, [0004], [0006], [0010], [0028] *;
		[X]US2017151339 (WHITE BRIAN H [US], et al) [X] 16 * ; entire document, especially para [0006]-[0007], [0124], [0277]-[0278], [0346] *;
		[X] - RODZINSKI et al., "Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles", Scientific Reports, (20160215), vol. 6, page 20867, XP055561238 [X] 10-13 * ; entire document, especially pg 1 para 1, pg 1 para 4, pg 3 para 1, pg 8 Fig 6, pg 11 para 1-2 * DOI: http://dx.doi.org/10.1038/srep20867
		[XY] - HOLMKVIST et al., "Hydrophobic ion pairing of a minocycline/Ca2+/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release", International Journal of Pharmaceutics, (20160107), vol. 499, pages 351 - 357, XP029405111 [X] 14, 17 * ; entire document, especially abstract, pg 353 col 2 para 3 * [Y] 18 DOI: http://dx.doi.org/10.1016/j.ijpharm.2016.01.011
		[A] - Anonymous, "Polycaprolactone", Wikipedia, (20160605), pages 1 - 4, URL: https://en.wikipedia.org/w/index.php?title=Polycaprolactone&oldid=723770231, (20180904), XP055660982 [A] 1-9, 15 * ; entire document, especially pg 2 para 1 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p